Elevance Health, Inc. in 2 stories
The narratives ELV currently appears in, with its side and exposure in each.
Bull side
1 story- America Imports the World's Drug Prices
ELV in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Elevance and its CarelonRx pharmacy-benefit operation stand to benefit from lower branded-drug reimbursement and stronger access to generic and biosimilar substitutes.
Bear side
1 story- Managed Care's Margin Machine Breaks
ELV in “Managed Care's Margin Machine Breaks”
FadingExposure: not rated yetRising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.
Higher claims trends and government-program rate pressure threaten underwriting margins across Elevance's insurance portfolio.